Clinical trials: Immunotoxicity

Immunotoxicity, Vaccine

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

• Completed
• Age: 8 to 12 months
• Phase 4
• Vaccines
• Injection or infusion

To evaluate the immunogenicity, lot-to-lot consistency and safety of three consecutive batches of Measles, Mumps and Rubella Combined Vaccine, Live.

Trial name

NCT05161845

Testing

Measles, Mumps and Rubella Combined Vaccine, Live

Where

China

Volunteers

1,068 people, healthy volunteers welcome

Sponsor

Shanghai Institute Of Biological Products